作者
Florentina Simader,Christopher Rajkumar,Michael Foley,Fiyyaz Ahmed‐Jushuf,Shayna Chotai,Nina Bual,A. M. Khokhär,Aisha Gohar,Ioannis M. Lampadakis,Sashiananthan Ganesananthan,Rachel H. Pathimagaraj,Alexandra N. Nowbar,John R. Davies,Thomas R. Keeble,Peter O’Kane,Peter Haworth,Helen Routledge,Tushar Kotecha,James C. Spratt,Rupert Williams,Sukhjinder Nijjer,Sayan Sen,Nick Curzen,Manas Sinha,James P. Howard,Graham Cole,Frank E. Harrell,Dárrel P. Francis,Matthew Shun-Shin,Rasha Al‐Lamee
摘要
Placebo-controlled evidence from ORBITA-2 found that percutaneous cutaneous intervention (PCI) in stable coronary artery disease with little or no antianginal medication relieved angina, but residual symptoms persisted in many. The reason for this was unclear.